Volume 34, Issue 3 pp. 357-364

Antiarrhythmic Effect of Reverse Electrical Remodeling Associated with Cardiac Resynchronization Therapy

LARISA G. TERESHCHENKO M.D., Ph.D.

LARISA G. TERESHCHENKO M.D., Ph.D.

Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland

Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri

Search for more papers by this author
CHARLES A. HENRIKSON M.D.

CHARLES A. HENRIKSON M.D.

Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland

Search for more papers by this author
PETER STEMPNIEWICZ B.S.

PETER STEMPNIEWICZ B.S.

Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland

Search for more papers by this author
LICHY HAN

LICHY HAN

Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland

Search for more papers by this author
RONALD D. BERGER M.D., Ph.D.

RONALD D. BERGER M.D., Ph.D.

Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland

Search for more papers by this author
First published: 22 November 2010
Citations: 21
Address for reprints: Larisa G. Tereshchenko, M.D., Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Carnegie 568, 600 N. Wolfe St., Baltimore, MD 21287. Fax: 410-614-8039; e-mail: [email protected]

Disclosures: This study was partially supported by Medtronic, Inc. as an Investigator-initiated Research Project (awarded to Drs. Berger and Tereshchenko). Other co-authors have nothing to disclose. Registration identification number NCT00916435.

Abstract

Background: Antiarrhythmic and proarrhythmic effects of cardiac resynchronization therapy (CRT) remain controversial. We hypothesized that reverse electrical remodeling (RER) with CRT is associated with reduced frequency of ventricular tachyarrhythmias (VTs).

Methods: The width of native and paced QRS was measured in lead II electrocardiogram before and 13 ± 7 months after implantation of a CRT defibrillator device in 69 patients (mean age 66.3 ± 13.9; 39 males [83%]) with bundle branch block (BBB) (41 patients with left BBB and three patients with bifascicular block) or nonspecific intraventricular conduction delay (25 patients, 36%), and New York Heart Association class III–IV heart failure. Biventricular pacing was inhibited for 10 seconds to record native QRS. RER was defined as a decrease in the native QRS duration ≥10 ms compared to preimplant. Patients were followed prospectively 24 ± 13 months after assessment for electrical remodeling.

Results: RER was observed in 22 patients (32%), among whom QRS duration decreased by 30.9 ± 14.1 ms (P < 0.00001) with similar heart rate and QRS morphology. Native QRS duration increased by 10.3 ± 16.6 ms in the other 47 patients (68%) (P = 0.0001). Baseline mean ejection fraction did not differ between patients with and those without RER (24.9 ± 10.0 vs 24.2 ± 8.6%, NS). During 2 ± 1 years of further follow-up, 19 patients had VTs and 12 patients died. RER was associated with a fourfold decrease in the risk of death or sustained VTs requiring appropriate implantable cardioverter-defibrillator therapies, whichever came first (hazard ratio 0.25; 95% confidence interval 0.08–0.85; P = 0.026).

Conclusion: RER of the native conduction with CRT is associated with decreased mortality and antiarrhythmic effect of CRT. (PACE 2011; 34:357–364)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.